Bill Arthur

Bill Arthur, PhD has a diverse and extensive work experience in the biotechnology and pharmaceutical industry. Bill has served in various leadership roles, including Senior Vice President of Research at Immunome, Inc., CEO of Stealth Mode Biotech, and Vice President of Research & Translational Sciences at Neoleukin Therapeutics. Prior to these positions, they held roles at Seagen, Presage Biosciences, Merck, Rosetta Inpharmatics, and Fred Hutch, showcasing their expertise in cancer biology, drug target discovery, and genomic profiling.

Bill Arthur earned their Ph.D. in Cell & Developmental Biology from the University of North Carolina at Chapel Hill from 1998 to 2002.